ASHP—Preventing and Treating Recurrent Cdiff Infection in High-Risk Populations (Advanced Practice)
February 1, 2021 - May 31, 2022
February 1, 2021
May 31, 2022
This free, 1.5-hour interprofessional online continuing education program is available free on the American Society of Health-System Pharmacists website through May 31, 2022. The target audience is pharmacists, physician assistants, or nurse practitioners who care for patients at risk for recurrent Clostridioides difficile Infection.
ObjectivesThis 1.5-hour interprofessional educational activity uses a point-counterpoint approach to decision making for managing special patient populations at high-risk for poor outcomes also taking into account cost-benefit considerations. Learning objectives:
- Distinguish how current Clostridioides difficile infection (CDI) therapies prevent CDI recurrence.
- Identify patients that would benefit from fidaxomicin or vancomycin with another anti-CDI recurrence strategy.
- Identify patient populations in which an anti-CDI recurrence strategy would be most cost effective in practice.
- Develop an interprofessional treatment plan for recurrent CDI for special populations.
Registration for the online program is available on the ASHP website: http://symposia.ashp.org/lms/content/21-highriskcdiff/